MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Inicio・Lista de Acciones・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Abierto

1.35 3.05

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.31

Máximo

1.3599999999999999

Métricas clave
By Trading Economics
Ingresos	2.7M -24M
BPA	-0.354
Empleados	49
EBITDA	-5.3M -28M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+102.27% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-8.4M 73M
Apertura anterior	-1.7
Cierre anterior	1.35

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

1.43 / 1.6 Soporte y Resistencia

Pliant Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 abr 2026, 17:11 UTC

Principales Movimientos del Mercado

Noticias de Eventos Importantes

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2 abr 2026, 17:10 UTC

Noticias de Eventos Importantes

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2 abr 2026, 23:47 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2 abr 2026, 21:01 UTC

Noticias de Eventos Importantes

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2 abr 2026, 20:59 UTC

Adquisiciones, fusiones, absorciones

Starbucks and Boyu Capital Finalize China JV

2 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

2 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

2 abr 2026, 20:41 UTC

Ganancias

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 abr 2026, 20:32 UTC

Charlas de Mercado

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2 abr 2026, 20:30 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 20:09 UTC

Charlas de Mercado

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2 abr 2026, 20:01 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 19:46 UTC

Charlas de Mercado

Is Oil the New GameStop? -- Market Talk

2 abr 2026, 19:35 UTC

Charlas de Mercado

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2 abr 2026, 19:29 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 19:24 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2 abr 2026, 19:20 UTC

Charlas de Mercado

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2 abr 2026, 19:01 UTC

Adquisiciones, fusiones, absorciones

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2 abr 2026, 19:00 UTC

Adquisiciones, fusiones, absorciones

Union Pacific: Agreement Reached With American Train Dispatchers Association

2 abr 2026, 18:24 UTC

Adquisiciones, fusiones, absorciones

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2 abr 2026, 17:44 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2 abr 2026, 17:32 UTC

Noticias de Eventos Importantes

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2 abr 2026, 17:26 UTC

Ganancias

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 abr 2026, 17:17 UTC

Charlas de Mercado

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2 abr 2026, 17:09 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Comparación entre iguales

Cambio de precio

Pliant Therapeutics Inc previsión

Precio Objetivo

By TipRanks

102.27% repunte

Estimación a 12 Meses

Media 2.67 USD 102.27%

Máximo 3 USD

Mínimo 2 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pliant Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Pliant Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.43 / 1.6Soporte y Resistencia

Recent bearish events outweigh bullish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.